Bruton's tyrosine kinase is a potential therapeutic target in prostate cancer

Bruton's tyrosine kinase (BTK) is a non-receptor tyrosine kinase that has mainly been studied in haematopoietic cells. We have investigated whether BTK is a potential therapeutic target in prostate cancer. We find that BTK is expressed in prostate cells, with the alternate BTK-C isoform predomi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Cancer Biol Ther
Autors principals: Kokabee, Leila, Wang, Xianhui, Sevinsky, Christopher J, Wang, Wei Lin Winnie, Cheu, Lindsay, Chittur, Sridar V, Karimipoor, Morteza, Tenniswood, Martin, Conklin, Douglas S
Format: Artigo
Idioma:Inglês
Publicat: Taylor & Francis 2015
Matèries:
Research Papers
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC4846115/
https://ncbi.nlm.nih.gov/pubmed/26383180
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/15384047.2015.1078023
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars